Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EF.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EF.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EF.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EF.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EF.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.32ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.32ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.32EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EK.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EK.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EK.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EK.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.6.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.6.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.6.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.6.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2 (Omicron)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2 (Omicron)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2 (Omicron)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used